Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Berotralstat (BCX7353) | 1809010-50-1 | MFCD33023491 | 99.7% | 562.6 g/mol | C30H26F4N6O | 5 MG
Supplier: Medchemexpress LLC HY1091275MG
Berotralstat is a selective, orally active plasma kallikrein inhibitor used in research and clinical development, including prophylaxis studies for hereditary angioedema and investigational work on edema and glioblastoma models. This item is provided as a research-grade solid standard (5 mg) intended for analytical, preclinical, and formulation studies, with documented batch-level characterization and supporting analytical data.
- Selective plasma kallikrein inhibitor for HAE and related research
- Supplied as a 5 mg research-grade solid suitable for analytical use
- High HPLC purity (reported ~99.7%) for reliable results
- Documented certificate of analysis and batch data available
- Suitable for biochemical assays, formulation studies, and reference standards
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?